Our findings reveal that besides regulating TRAIL-R2/DR5 oligomerization, ECM stiffness is also modulating a YAP/TAZ-mediated signaling mechanism to control cFLIP expression in tumor cells. The gene discussed is TNFRSF10B; the disease is neoplasm.